Guzmán Prieto Ana M, Wijngaarden Jessica, Braat Johanna C, Rogers Malbert R C, Majoor Eline, Brouwer Ellen C, Zhang Xinglin, Bayjanov Jumamurat R, Bonten Marc J M, Willems Rob J L, van Schaik Willem
Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands.
Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02122-16. Print 2017 May.
is one of the primary causes of nosocomial infections. Disinfectants are commonly used to prevent infections with multidrug-resistant in hospitals. Worryingly, strains that exhibit tolerance to disinfectants have already been described. We aimed to identify and characterize genes that contribute to tolerance to the disinfectant chlorhexidine (CHX). We used a transposon mutant library, constructed in a multidrug-resistant bloodstream isolate, to perform a genome-wide screen to identify genetic determinants involved in tolerance to CHX. We identified a putative two-component system (2CS), composed of a putative sensor histidine kinase (ChtS) and a cognate DNA-binding response regulator (ChtR), which contributed to CHX tolerance in Targeted and deletion mutants exhibited compromised growth in the presence of CHX. Growth of the and mutants was also affected in the presence of the antibiotic bacitracin. The CHX- and bacitracin-tolerant phenotype of E1162 was linked to a unique, nonsynonymous single nucleotide polymorphism in Transmission electron microscopy showed that upon challenge with CHX, the Δ and Δ mutants failed to divide properly and formed long chains. Normal growth and cell morphology were restored when the mutations were complemented in Morphological abnormalities were also observed upon exposure of the Δ and Δ mutants to bacitracin. The tolerance to both chlorhexidine and bacitracin provided by ChtRS in highlights the overlap between responses to disinfectants and antibiotics and the potential for the development of cross-tolerance for these classes of antimicrobials.
是医院感染的主要原因之一。消毒剂常用于预防医院中多重耐药菌的感染。令人担忧的是,已经发现了对消毒剂具有耐受性的菌株。我们旨在鉴定和表征有助于对消毒剂洗必泰(CHX)产生耐受性的基因。我们使用在多重耐药血流分离株中构建的转座子突变体文库进行全基因组筛选,以鉴定参与对CHX耐受性的遗传决定因素。我们鉴定出一个假定的双组分系统(2CS),由一个假定的传感器组氨酸激酶(ChtS)和一个同源的DNA结合反应调节因子(ChtR)组成,它们有助于[具体细菌名称未给出]对CHX的耐受性。靶向的[具体基因未给出]和[具体基因未给出]缺失突变体在CHX存在下生长受损。在抗生素杆菌肽存在的情况下,[具体细菌名称未给出]和[具体细菌名称未给出]突变体的生长也受到影响。[具体细菌名称未给出]E1162对CHX和杆菌肽的耐受性表型与[具体基因未给出]中的一个独特的非同义单核苷酸多态性有关。透射电子显微镜显示,在用CHX攻击时,Δ[具体基因未给出]和Δ[具体基因未给出]突变体不能正常分裂并形成长链。当突变在[具体细菌名称未给出]中得到互补时,恢复了正常生长和细胞形态。在将Δ[具体基因未给出]和Δ[具体基因未给出]突变体暴露于杆菌肽时也观察到形态异常。ChtRS在[具体细菌名称未给出]中提供的对洗必泰和杆菌肽的耐受性突出了对消毒剂和抗生素反应之间的重叠以及这些类别的抗菌剂产生交叉耐受性的可能性。